Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial (Q36026210)

11 August 2017

Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial (English)

1 reference

11 August 2017

phase I clinical trial

0 references

0 references

8

Richard G Jarman

1 reference

11 August 2017

9

Jeffrey R Currier

1 reference

11 August 2017

Rafael A De La Barrera

6

object named as

Rafael De La Barrera

1 reference

11 August 2017

14

Kenneth H Eckels

1 reference

11 August 2017

7

Monika Simmons

1 reference

11 August 2017

11

Janine R Danko

1 reference

11 August 2017

13

J Robert Putnak

1 reference

11 August 2017

Luis Javier Martinez

1

1 reference

11 August 2017

Leyi Lin

2

1 reference

11 August 2017

Jason M Blaylock

3

1 reference

11 August 2017

Arthur G Lyons

4

1 reference

11 August 2017

Kristen M Bauer

5

1 reference

11 August 2017

Heather Friberg

10

1 reference

11 August 2017

Nimfa C Teneza-Mora

12

1 reference

11 August 2017

Stephen J Thomas

15

1 reference

11 August 2017

language of work or name

English

0 references

publication date

6 July 2015

1 reference

American Journal of Tropical Medicine and Hygiene

11 August 2017

1 reference

11 August 2017

93

1 reference

11 August 2017

3

1 reference

11 August 2017

454-460

1 reference

Efficacy of a tetravalent dengue vaccine in children in Latin America.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Developing a dengue vaccine: progress and future challenges

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Dengue virus vaccine development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Identifying protective dengue vaccines: guide to mastering an empirical process

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Challenges in the clinical development of a dengue vaccine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

The global distribution and burden of dengue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Cost-effectiveness of a pediatric dengue vaccine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

TBE vaccination and the Austrian experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

The necessity and quandaries of dengue vaccine development

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Antibody dynamics after tick-borne encephalitis and measles–mumps–rubella vaccination in children post early thymectomy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO].

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4559679

From the Centers for Disease Control and Prevention. Dengue fever among U.S. military personnel--Haiti, September-November, 1994

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26149862

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26149862

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4269/AJTMH.14-0819

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

26149862

1 reference